-
NFL Alumni Back New Drug to Keep Brain-Injuries From “Destroying Quality of Life”
The NSI-189/TBI initiative by Neuralstem and the National Football League Alumni Association, to develop a trial to treat traumatic brain injury for former NFL players, is spotlighted.
Select media coverage in this website is provided for the information and convenience of the public, and is not intended to be all-encompassing nor an endorsement of the specific stories or media outlets.